Li, Li
Yang, Hai-Yan
Ma, Yan
Liang, Xing-Huan
Xu, Min
Zhang, Jie
Huang, Zhen-Xing
Meng, Li-Heng
Zhou, Jia
Xian, Jing
Suo, Ying-Jun
Huang, Song
Cai, Jin-Wei
Meng, Bi-Hui
Zhao, Zhi-Yun
Lu, Jie-Li
Xu, Yu
Wang, Tian-Ge
Li, Mian
Chen, Yu-Hong
Wang, Wei-Qing
Bi, Yu-Fang
Ning, Guang
Shen, Fei-Xia
Hu, Ru-Ying
Chen, Gang
Chen, Li
Chen, Lu-Lu
Deng, Hua-Cong
Gao, Zheng-Nan
Huo, Ya-Nan
Li, Qiang
Liu, Chao
Mu, Yi-Ming
Qin, Gui-Jun
Shi, Li-Xin
Su, Qing
Wan, Qin
Wang, Gui-Xia
Wang, Shuang-Yuan
Wang, You-Min
Wu, Sheng-Li
Xu, Yi-Ping
Yan, Li
Yang, Tao
Ye, Zhen
Yu, Xue-Feng
Zhang, Yin-Fei
Zhao, Jia-Jun
Zeng, Tian-Shu
Tang, Xu-Lei
Qin, Ying-Fen
Luo, Zuo-Jie http://orcid.org/0000-0003-2969-8329
,
Funding for this research was provided by:
National Natural Science Foundation of China (81860146, 81660138)
Traditional Chinese Medicine Self-financing Project of Guangxi Zhuang Autonomous Region Administration (gzzc0964)
Department of Health Self-financing Research Projects of Guangxi Zhuang Autonomous Region of China (Z2002046, Z2010345, Z2015519)
National Key Research & Development Plan for Precision Medicine Key Program (2016YFC0901200, 2016YFC0901205)
Article History
Received: 7 February 2022
Accepted: 31 August 2022
First Online: 19 October 2022
Declarations
:
: The authors have no competing interests to declare that are relevant to the content of this article.
: The China Cardiometabolic Disease and Cancer Cohort (4C) Study was performed in accordance with the Declaration of Helsinki and was approved by the Medical Ethics Committee of Ruijin Hospital, Shanghai Jiaotong University (ethical approval number: 2011-14).
: Informed consent was obtained from all individual participants included in the study to participate and to publish their data.